PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.\', \'Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907, United States.\', \'Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907, United States.\', \'Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Shinjuku, Tokyo 162-8655, Japan.\', \'Department of Hematology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan.\', \'Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland 20892, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.jmedchem.1c01214
?:hasPublicationType
?:journal
  • Journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34528437
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.567
?:rankingScore_hIndex
  • 231
?:title
  • Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure-Activity Relationship, and X-ray Structural Studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32842979>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32842979>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all